Current Research in Medications Development
Research on Promising Medications (not approved by the U.S. Food and Drug Administration [FDA]) to Treat Alcohol Use Disorder (AUD) Varenicline (Chantix®), a medication approved for smoking cessation, was found in a recent 200-patient clinical trial conducted by NIAAA’s Clinical Investigations Group (NCIG) to reduce alcohol consumption and craving among people who are alcohol-dependent. Varenicline may work by partially stimulating...
In Memoriam: Ann Streissguth
ICCFASD Webinar - April 12, 2017
Understanding Fetal Alcohol Spectrum Disorders (FASD): Promising Practices for System Involved Youth with FASD FASD is a group of medical conditions that describe a range of effects that can occur in an individual prenatally exposed to alcohol. These effects, often invisible, may include mental, behavioral, and or learning disabilities with lifelong implications. This session will highlight available resources on this...
Interrupted Memories: Alcohol-Induced Blackouts
Appendix A. Differences Among Survey Data Sources
Appendix A. Differences Among Survey Data Sources
Goal 1: Building a Robust Research Capacity
40th Anniversary
Support & Treatment
Mission Statement
Donations to NIAAA
Can NIAAA accept donations? Yes. Although the NIAAA is a federally funded organization and not a fund-raising organization, the U.S. Congress has authorized NIAAA to accept donations and bequests to support its research mission. Donations to the NIAAA are deposited in a Gift Fund account which is separate from the funding NIAAA receives from Congress. How are donations used? Projects...
Medications Development Program
Treatment for alcohol use disorder (AUD) includes behavioral treatments such as mutual support groups and individual therapy, as well as pharmaceutical treatments. Often these are used in combination. Currently, there are three Food and Drug Administration (FDA)-approved medications for the treatment of AUD: Disulfiram (Antabuse®) In 1949, disulfiram became the first drug approved to treat alcoholism. The drug works by...
Resaca
NIAAA Expands its Social Media Presence to LinkedIn
NIAAA Releases Strategic Plan for Fiscal Years 2024-2028
Kicking off the new year with Dry January? Here are six tips for success
Major Initiatives
NIAAA’s major initiatives seek to address alcohol-related issues across the lifespan. Our aim is to reduce the tremendous burden of illness resulting from the misuse of alcohol by: Preventing children and adolescents from beginning and continuing to drink alcohol Offering effective intervention for problem alcohol use at all ages To accomplish this, we support research in areas ranging from basic...
In Memoriam - Enoch Gordis, MD
Interagency Work Group on Drinking and Drug Use in Women and Girls
In the 1990s, the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), began sponsoring the Work Group on Women, Drinking, and Pregnancy, one of four work groups then supported by the Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD). In 2018, the Work Group changed its name to the Interagency Work Group on Drinking...